Ionis Pharmaceuticals, Inc. Payments to Acquire Land
Ionis Pharmaceuticals, Inc. (IONS) reported Payments to Acquire Land of $10.10 million for the 1-month period ending 2010-03-31, per its 10-K filed 2016-02-26.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireLand · last filed 2016-02-26
- 2010-03-31: Payments to Acquire Land 1 month $10.10M; Payments to Acquire Land 1 month as first filed $10.20M.
| Period end | Payments to Acquire Land 1 month | Payments to Acquire Land 1 month as first filed |
|---|---|---|
| 2010-03-31 | $10.10M 10-K · filed 2016-02-26 | $10.20M 10-K · filed 2015-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |